Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Penicillin G + Hydrocortisone in ALS (PHALS)
2017-001983-39Phase 2Active
- Sponsor
- University Medical Center Utrecht
- Start
- Aug 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in amyotrophic lateral sclerosis (ALS) comparing Penicillin G + Hydrocortisone with Placebo (2 arms). Primary endpoint: Change in ALSFRS-R from baseline to week 45. Started Aug 2017; status: active.
02
Drugs
benzylpenicillinhydrocortisone
03
Conditions
amyotrophic lateral sclerosis (ALS)
Beyond the preview
Go deeper on 2017-001983-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001983-39.